Pharmaceutical Investing

Relevium’s CEO Provides an Open Shareholder Letter for 2020

Cannabis Investing News

Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

Cannabis Investing News

FSD Pharma Receives Approval to List Its Shares on Nasdaq

Cannabis Investing News

Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board

Pharmaceutical Investing

5 Top NASDAQ Biotech and Pharma Stocks: Neoleukin Up 98 Percent

Biotech Investing

FSD Pharma to Present at Investor Summit on December 17

Cannabis Investing News

BioXcel Therapeutics to Expand BXCL701 Study

Biotech Investing

Dare Biosciences and FDA Align on Phase 2b Study Design of Sildenafil

Biotech Investing

Avenue Therapeutics Submits New Drug Application for IV Tramadol

Pharmaceutical Investing

Algernon Pharmaceuticals to Present at 12th Annual LD Micro Main Event Conference on Wednesday December 11, 2019

Pharmaceutical Investing

Ocugen Completes 50 Percent Enrollment in Phase 3 Clinical Trial

Biotech Investing

Achillion Reports Positive Data from Phase 2 Study of Danicopan

Biotech Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES